Acadia Pharmaceuticals (ACAD)

Acadia Pharmaceuticals (ACAD)

Postby winston » Wed Jan 01, 2014 7:59 am

not vested

Acadia Pharmaceuticals Inc., a biopharmaceutical company, focuses on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders.

The company has a pipeline of product candidates led by pimavanserin, which is in Phase III development as a potential first-in-class treatment for Parkinson’s disease psychosis.

It also has clinical-stage programs for chronic pain and glaucoma in collaboration with Allergan, Inc. and two advanced preclinical programs directed at Parkinson’s disease and other neurological disorders.

http://todaysbigstock.com/2013/12/31/ac ... sdaq-acad/
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Acadia Pharmaceuticals (ACAD)

Postby winston » Thu Jun 09, 2016 9:14 am

not vested

Acadia Pharmaceuticals Inc.: 7 Companies That Could Buy ACAD

ACAD likely has many interested buyers on the line for its drug Nuplazid, the big question is whether those offers are good enough

By Brian Nichols

Source: Investor Place

http://investorplace.com/2016/06/7-comp ... 1i3Avl96M8
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Acadia Pharmaceuticals (ACAD)

Postby winston » Tue Jul 12, 2016 7:21 am

not vested

ACAD hits key level at $35

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders.

Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson’s disease psychosis and the Phase II trial for the treatment of schizophrenia, as well as is in Phase II study for the treatment of Alzheimer’s disease psychosis.

Source: Wealth Blueprint Letter

http://wealthblueprintletter.com/acad-h ... a4e25051c5
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am


Return to A to D

Who is online

Users browsing this forum: No registered users and 14 guests